Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Relationship of Glycated Albumin to Blood Glucose and HbA1c Values and to Retinopathy, Nephropathy, and Cardiovascular Outcomes in the DCCT/EDIC Study

Open access
Nathan, David M., McGee, Paula, Steffes, Michael W., Lachin, John M., the DCCT/EDIC Research Group · 2014 · Diabetes

Abstract

The association of chronic glycemia, measured by HbA1c, with long-term complications of type 1 diabetes has been well established in the Diabetes Control and Complications Trial (DCCT) and other studies. The role of intermediate-term and acute glycemia and of glucose variability on microvascular and cardiovascular disease (CVD) is less clear. In order to examine the interrelationships among long-term, intermediate-term, and acute measures of glucose and its daily variability, we compared HbA1c, glycated albumin (GA), and seven-point glucose profile concentrations measured longitudinally in a case-cohort subpopulation of the DCCT. HbA1c and GA were closely correlated with each other and with the mean blood glucose (MBG) calculated from the seven-point profile. The associations of glucose variability and postprandial concentrations with HbA1c and GA were relatively weak and were further attenuated when MBG was included in multivariate models. In the case-cohort analyses, HbA1c and GA had similar associations with retinopathy and nephropathy, which were strengthened when both measures were considered together. Only HbA1c was significantly associated with CVD. The demonstrated interrelationships among different measures of glycemia will need to be considered in future analyses of their roles in the development of long-term complications of type 1 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db13-0782

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Scatterplot of all GA vs. HbA1c values. The slope is a 3.37 increase in GA % per unit increase in HbA1c % (SE = 0.118; P < 0.0001), with R2 = 0.746.
Figure 1 Scatterplot of all GA vs. HbA1c values. The slope is a 3.37 increase in GA % per unit increase in HbA1c % (SE = 0.118; P < 0.0001), with R2 = 0.746.CC BY-NC-ND · PubMed Central
Figure 2 Weighted estimates of the mean ± 95% CI of measures of glycemia at each annual visit during the DCCT in the aggregate cohort (N = 497) obtained from a longitudinal model with separate estimates for each group at each visit. A: GA. B: MBG. C: HbA1c. Computed as the average of the values at each visit from the 10 imputed datasets with no missing values. Sample sizes at each year of 497, 497, 496, 494, 492, 446, 332, and 214. Observations weighted by the inverse sampling probabilities within strata defined by DCCT Treatment Group, primary vs. secondary cohort, and whether a case of retinopathy, nephropathy, or CVD. CONV, conventional group; INT, intensive group.
Figure 2 Weighted estimates of the mean ± 95% CI of measures of glycemia at each annual visit during the DCCT in the aggregate cohort (N = 497) obtained from a longitudinal model with separate estimates for each group at each visit. A: GA. B: MBG. C: HbA1c. Computed as the average of the values at each visit from the 10 imputed datasets with no missing values. Sample sizes at each year of 497, 497, 496, 494, 492, 446, 332, and 214. Observations weighted by the inverse sampling probabilities within strata defined by DCCT Treatment Group, primary vs. secondary cohort, and whether a case of retinopathy, nephropathy, or CVD. CONV, conventional group; INT, intensive group.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Research works printed but not linked: 1

  1. Nagamine, 2004, Evaluation of the enzymatic method for glycated albumin with liquid type reagent (Lucia GA-L), Jpn J Med Pharm Sci, 51, 737

Cited by

See all 214

Metadata

Authors
Nathan, D. M., McGee, P., Steffes, M. W., Lachin, J. M., & the DCCT/EDIC Research Group
Affiliations
  • Harvard University (US)
  • George Washington University (US)
  • University of Minnesota (US)
Corresponding author
McGee, Paula
Venue
Diabetes
Published
2013-12-13
Volume
63
Issue
1
Pages
282-290
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2139557453
Cited by
214
References
37
Citations by year
2026: 4 · 2025: 6 · 2024: 14 · 2023: 19 · 2022: 19 · 2021: 9 · 2020: 19 · 2019: 16 · 2018: 24 · 2017: 23 · 2016: 22 · 2015: 14 · 2014: 20 · 2013: 4
FWCI
15.76
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (UL1TR000041, UL1TR001449)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
glycated albumin, HbA1c, blood glucose, glycemic variability, type 1 diabetes, diabetic retinopathy, diabetic nephropathy, cardiovascular disease, microvascular complications, mean blood glucose, postprandial blood glucose, DCCT/EDIC
MeSH terms
Glycated Serum Albumin, Adolescent, Adult, Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Type 1, Diabetic Nephropathies, Diabetic Retinopathy, Glycated Hemoglobin, Humans, Serum Albumin, Severity of Illness Index, Glycation End Products, Advanced

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Relationship of Glycated Albumin to Blood Glucose and HbA1c Values and to Retinopathy, Nephropathy, and Cardiovascular Outcomes in the DCCT/EDIC Study. https://app.cochat.ai/papers/10.2337/db13-0782
The paper
Nathan, D. M., McGee, P., Steffes, M. W., Lachin, J. M., & the DCCT/EDIC Research Group. (2014). Relationship of Glycated Albumin to Blood Glucose and HbA1c Values and to Retinopathy, Nephropathy, and Cardiovascular Outcomes in the DCCT/EDIC Study. Diabetes. https://doi.org/10.2337/db13-0782

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.